Segall Bryant & Hamill’s Adient ADNT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.52M Buy
82,766
+13,305
+19% +$284K 0.02% 499
2026
Q1
$1.4M Buy
+69,461
New +$1.54M 0.02% 457
2017
Q1
Sell
-4,935
Closed -$289K 550
2016
Q4
$289K Buy
+4,935
New +$261K 0.01% 474

Other funds holding ADNT

Segall Bryant & Hamill's ADNT Position: Q2 2026 in Review

Segall Bryant & Hamill increased its Adient (ADNT) stake by 19% in Q2 2026, buying an estimated $284K and bringing the position to 82,766 shares worth $1.52M. The position accounts for 0.02% of the portfolio, ranked #499.

Segall Bryant & Hamill first reported a position in ADNT in Q4 2016 and has held it in 3 quarters since. 314 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.

  • Segall Bryant & Hamill held 82,766 shares of Adient worth $1.52M as of Q2 2026.
  • Segall Bryant & Hamill bought 13,305 Adient shares in Q2 2026, an estimated $284K.
  • Adient made up 0.02% of Segall Bryant & Hamill's portfolio in Q2 2026, its #499 holding.
  • Segall Bryant & Hamill first reported a position in Adient in Q4 2016 and has held it in 3 quarters since.
  • 314 funds tracked by Wall St. Rank held Adient as of Q2 2026.

Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.